|
1
|
Schick B and Kahle G: Radiological
findings in angiofibroma. Acta Radiol. 41:585–593. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Banno K, Iida M, Yanokura M, Kisu I, Iwata
T, Tominaga E, Tanaka K and Aoki D: MicroRNA in cervical cancer:
OncomiRs and tumor suppressor miRs in diagnosis and treatment.
Scientific World Journal. 2014:1780752014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Janiszewska J, Szaumkessel M and Szyfter
K: microRNAs are important players in head and neck carcinoma: a
review. Crit Rev Oncol Hematol. 88:716–728. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Zhang XH, Zhang YN and Liu Z: MicroRNA in
chronic rhinosinusitis and allergic rhinitis. Curr Allergy Asthma
Rep. 14:4152014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Abraham SC, Montgomery EA, Giardiello FM
and Wu TT: Frequent beta-catenin mutations in juvenile
nasopharyngeal angiofibromas. Am J Pathol. 158:1073–1078. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Uesugi A, Kozaki K, Tsuruta T, Furuta M,
Morita K, Imoto I, Omura K and Inazawa J: The tumor suppressive
microRNA miR-218 targets the mTOR component Rictor and inhibits AKT
phosphorylation in oral cancer. Cancer Res. 71:5765–5778. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Wendler O, Dlugaiczyk J, Birk S and Schick
B: Anti-proliferative effect of glucocorticoids on mesenchymal
cells in juvenile angiofibromas. Head Neck. 34:1615–1621. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Du L, Schageman JJ, Subauste MC, Saber B,
Hammond SM, Prudkin L, Wistuba II, Ji L, Roth JA, Minna JD and
Pertsemlidis A: miR-93, miR-98, and miR-197 regulate expression of
tumor suppressor gene FUS1. Mol Cancer Res. 7:1234–1243. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Tran N, McLean T, Zhang X, Zhao CJ,
Thomson JM, O’Brien C and Rose B: MicroRNA expression profiles in
head and neck cancer cell lines. Biochem Biophys Res Commun.
358:12–17. 2007. View Article : Google Scholar
|
|
10
|
Alajez NM, Shi W, Hui AB, Bruce J,
Lenarduzzi M, Ito E, Yue S, O’Sullivan B and Liu FF: Enhancer of
Zeste homolog 2 (EZH2) is overexpressed in recurrent nasopharyngeal
carcinoma and is regulated by miR-26a, miR-101, and miR-98. Cell
Death Dis. 1:e852010. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Childs G, Fazzari M, Kung G, Kawachi N,
Brandwein-Gensler M, McLemore M, Chen Q, Burk RD, Smith RV,
Prystowsky MB, et al: Low-level expression of microRNAs let-7d and
miR-205 are prognostic markers of head and neck squamous cell
carcinoma. Am J Pathol. 174:736–745. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Chang CJ, Hsu CC, Chang CH, Tsai LL, Chang
YC, Lu SW, Yu CH, Huang HS, Wang JJ, Tsai CH, et al: Let-7d
functions as novel regulator of epithelial-mesenchymal transition
and chemoresistant property in oral cancer. Oncol Rep.
26:1003–1010. 2011.PubMed/NCBI
|
|
13
|
Hashiguchi Y, Nishida N, Mimori K, Sudo T,
Tanaka F, Shibata K, Ishii H, Mochizuki H, Hase K, Doki Y and Mori
M: Down-regulation of miR-125a-3p in human gastric cancer and its
clinicopathological significance. Int J Oncol. 40:1477–1482.
2012.PubMed/NCBI
|
|
14
|
Guo X, Wu Y and Hartley RS: MicroRNA-125a
represses cell growth by targeting HuR in breast cancer. RNA Biol.
6:575–583. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Jiang L, Huang Q, Chang J, Wang E and Qiu
X: MicroRNA HSA-miR-125a-5p induces apoptosis by activating p53 in
lung cancer cells. Exp Lung Res. 37:387–398. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Nishida N, Mimori K, Fabbri M, Yokobori T,
Sudo T, Tanaka F, Shibata K, Ishii H, Doki Y and Mori M:
MicroRNA-125a-5p is an independent prognostic factor in gastric
cancer and inhibits the proliferation of human gastric cancer cells
in combination with trastuzumab. Clin Cancer Res. 17:2725–2733.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Wang G, Mao W, Zheng S and Ye J: Epidermal
growth factor receptor-regulated miR-125a-5p - a metastatic
inhibitor of lung cancer. FEBS J. 276:5571–5578. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Odar K, Boštjančič E, Gale N, Glavač D and
Zidar N: Differential expression of microRNAs miR-21, miR-31,
miR-203, miR-125a-5p and miR-125b and proteins PTEN and p63 in
verrucous carcinoma of the head and neck. Histopathology.
61:257–265. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Lajer CB, Nielsen FC, Friis-Hansen L,
Norrild B, Borup R, Garnæs E, Rossing M, Specht L, Therkildsen MH,
Nauntofte B, et al: Different miRNA signatures of oral and
pharyngeal squamous cell carcinomas: a prospective translational
study. Br J Cancer. 104:830–840. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Yamamoto N, Kinoshita T, Nohata N, Itesako
T, Yoshino H, Enokida H, Nakagawa M, Shozu M and Seki N: Tumor
suppressive microRNA-218 inhibits cancer cell migration and
invasion by targeting focal adhesion pathways in cervical squamous
cell carcinoma. Int J Oncol. 42:1523–1532. 2013.PubMed/NCBI
|
|
21
|
Li Y, Liu J, Yuan C, Cui B, Zou X and Qiao
Y: High-risk human papillomavirus reduces the expression of
microRNA-218 in women with cervical intraepithelial neoplasia. J
Int Med Res. 38:1730–1736. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Martinez I, Gardiner AS, Board KF, Monzon
FA, Edwards RP and Khan SA: Human papillomavirus type 16 reduces
the expression of microRNA-218 in cervical carcinoma cells.
Oncogene. 27:2575–2582. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Katoh M and Katoh M: Cross-talk of WNT and
FGF signaling pathways at GSK3beta to regulate beta-catenin and
SNAIL signaling cascades. Cancer Biol Ther. 5:1059–1064. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Alqurashi N, Hashimi SM and Wei MQ:
Chemical inhibitors and microRNAs (miRNA) targeting the mammalian
target of rapamycin (mTOR) pathway: potential for novel anticancer
therapeutics. Int J Mol Sci. 14:3874–3900. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Beham A, Beham-Schmid C, Regauer S, Auböck
L and Stammberger H: Nasopharyngeal angiofibroma: true neoplasm or
vascular malformation? Adv Anat Pathol. 7:36–46. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Schick B, Plinkert PK and Prescher A:
Aetiology of angiofibromas: reflection on their specific vascular
component. Laryngorhinootologie. 81:280–284. 2002.(In German).
|
|
27
|
Schick B, Wemmert S, Willnecker V,
Dlugaiczyk J, Nicolai P, Siwiec H, Thile CT, Rauch A and Wendler O:
Genome-wide copy number profiling using a 100K SNP array reveals
novel disease-related genes BORIS and TSHZ1 in juvenile
angiofibroma. Int J Oncol. 39:1143–1151. 2011.PubMed/NCBI
|
|
28
|
Starlinger V, Wendler O, Gramann M and
Schick B: Laminin expression in juvenile angiofibromas indicates
vessel’s early developmental stage. Acta Otolaryngol.
127:1310–1315. 2007.PubMed/NCBI
|
|
29
|
Small EM, Sutherland LB, Rajagopalan KN,
Wang S and Olson EN: MicroRNA-218 regulates vascular patterning by
modulation of Slit-Robo signaling. Circ Res. 107:1336–1344. 2010.
View Article : Google Scholar : PubMed/NCBI
|
